Search Within

Connie Wing-Ching Lee Batlevi

Formats
  1. Meeting Abstract (109)
  2. Journal Article (52)
  3. Research Letter (5)
  4. Book Section (4)
  5. Miscellaneous (2)
  6. Review (2)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (176)
  2. Department of Medicine (176)
  3. Hematologic Malignancies, Division of (176)
  4. Lymphoma (176)
  5. Survivorship Research (117)
  6. Epidemiology and Biostatistics (89)

More Groups

People
  1. Maria Palomba (98)
  2. Anas Younes (81)
  3. Andrew Zelenetz (76)
  4. Matthew Matasar (70)
  5. David Straus (61)
  6. Ariela Noy (60)

More People

Years
  1. 2024 (2)
  2. 2023 (11)
  3. 2022 (30)
  4. 2021 (27)
  5. 2020 (27)
  6. 2019 (34)

More Years

Publications
  1. Blood (69)
  2. Hematological Oncology (16)
  3. Blood Advances (12)
  4. Journal of Clinical Oncology (10)
  5. Blood Cancer Journal (6)
  6. Biology of Blood and Marrow Transplantation (5)

More Publications

Publishers
  1. American Society of Hematology (82)
  2. Wiley Blackwell (16)
  3. Elsevier Inc. (15)
  4. Nature Publishing Group (15)
  5. American Society of Clinical Oncology (10)
  6. John Wiley & Sons (4)

More Publishers

Results (176)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma
    Journal Article

    Umakanthan, J. M.; Iqbal, J.; Batlevi, C. L.; Bouska, A.; Smith, L. M.; Shostrom, V.; Nutsch, H.; William, B. M.; Gregory Bociek, R.; Lunning, M.; more...
    British Journal of Haematology (2019)

    Fulltext@MSK | Save
  • Surrogate end points in lymphoma
    Journal Article

    Batlevi, C. L.; Younes, A.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Clinical neurological features and electrographic patterns of patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene ciloleucel at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Sequeira, A.; Mao, D.; Chen, X.; Avila, E.; Mead, E.; Sauter, C. S.; Palomba, M. L.; Dahi, P. B.; Batlevi, C. L.; Shah, G.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Batlevi, C. L.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R. R.; Bernal, Y.; Hall, M.; Pineda, J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study
    Meeting Abstract

    McDonald, A.; Thomas, E.; Daigle, S.; Morschhauser, F.; Salles, G.; Ribrag, V.; McKay, P.; Tilly, H.; Schmitt, A.; Batlevi, C. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
    Journal Article

    Intlekofer, A. M.; Joffe, E.; Batlevi, C. L.; Hilden, P.; He, J.; Seshan, V. E.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, C. H.; Portlock, C.; more...
    Blood Cancer Journal (2018)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save